Peripheral isokinetic muscle function and cardiorespiratory capacity in coronary artery disease patients

被引:1
|
作者
Elleuch, M. H. [1 ]
Ghroubi, S.
Chaari, M.
Elleuch, H.
Massmoudi, K.
Abdenadher, M.
Trabelssi, I.
Akrout, M.
Feki, H.
Frikha, I.
Dammak, J.
Kammoun, S.
Zouari, N.
机构
[1] CHU Habib Bourguiba, Serv Med Phys & Reeduc Fonct, Sfax, Tunisia
[2] CHU Habib Bourguiba, Serv Explorat Fonct, Sfax, Tunisia
[3] CHU Habib Bourguiba, Serv Chirurg Cardiovasc, Sfax, Tunisia
[4] CHU Hedi Chaker, Serv Cardiol, Sfax, Tunisia
[5] CHU Hedi Chaker, Serv Med Prevent, Sfax, Tunisia
关键词
D O I
10.3233/IES-2007-0270
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Objective: The aim of this study was to determine if the diminished aerobic capacity of coronary artery disease (CAD) in male patients is accompanied by a peripheral impaired skeletal muscle function and to assess the correlation between the isokinetic strength and aerobic aptitude of these patients. Materials and methods: Fifteen CAD patients and 15 healthy subjects (age: 60 +/- 6 vs 57 +/- 3.5 years old) performed both maximal exercise testing, an isokinetic assessment of knee muscles and a 6-minute walking test. The quadriceps and hamstrings were tested at 150 and 180 degrees/s while being monitored with ECG. The cardio-respiratory and mechanical parameters (VO2, VT, HR, and power) were measured at ventilatory threshold and at maximal effort during a maximal exercise testing. Results: Isokinetic assessment was conducted successfully with all patients. No rhythm irregularity or hemodynamic anomalies were observed in the 2 groups. Muscle testing revealed significant strength impairment. Quadriceps peak torque, at 150 degrees/s was 77 +/- 16 Nm in patients vs. 99 +/- 23 Nm in controls, (p < 0.01) while at 180 degrees/s the values were 71 +/- 14 vs. 91 +/- 23 Nm, (p < 0.01), respectively. For the hamstrings the values were respectively 49 +/- 16 vs. 66 L 14 Nm, (p < 0.01) and 47 +/- 10 vs. 60 +/- 12 Nm, (p < 0.01). CAD subjects presented a deficient aerobic capacity compared to the healthy control group at maximal effort (Vo2 maximal uptake: Vo2 max: 20.34 +/- 4.95 vs. 29.16 +/- 7.68 ml mn(-1) kg(-1), (p = 0.01); maximal ventilation Ve max: 58.18 +/- 16.28 vs 84 +/- 24.45 ml mn(-1), (p < 0.05); heart rate: HR max: 118 +/- 21 vs 152 +/- 1 13 beats mn-1, (p < 0.001); maximal power: P max: 102 +/- 31 vs. 153 33 W. (p < 0.001) and at ventilatory threshold: VT (Vo2: 13.77 +/- 2.33 vs. 17.08 +/- 3.59 ml mn(-1) kg-1, (P < 0.05); VE: 29.64 +/- 6.64 vs. 37.76 +/- 7.2 ml mn(-1), (p < 0.05); HR: 86 14 vs. 111 +/- 15 beats mn(-1), (p = 0.001); but no significant difference was noticed for power (P: 61 +/- 12 vs. 76 +/- 24 W:). We also noticed that isokinetic muscle strength and O2 peak were not related to each other and are therefore independent. Conclusion: This study shows that CAD patients, compared to healthy subjects, have impaired cardio respiratory capacities which are accompanied by increased muscle fatigability. Isokinetic muscle strength and maximal aerobic capacity are independent of each other. An isokinetic muscle assessment in these patients must be conducted systematically and seems to have a considerable value in cardiovascular rehabilitation.
引用
收藏
页码:43 / 50
页数:8
相关论文
共 50 条
  • [41] Soluble RAGE Plasma Levels in Patients with Coronary Artery Disease and Peripheral Artery Disease
    Falcone, Colomba
    Bozzini, Sara
    Guasti, Luigina
    D'Angelo, Angela
    Capettini, Anna Clizia
    Paganini, Edoardo Maria
    Falcone, Rossana
    Moia, Roberto
    Gazzaruso, Carmine
    Pelissero, Gabriele
    SCIENTIFIC WORLD JOURNAL, 2013,
  • [42] Psychosocial outcome in cardiovascular rehabilitation of peripheral artery disease and coronary artery disease patients
    Stauber, Stefanie
    Guera, Viviane
    Barth, Juergen
    Schmid, Jean Paul
    Saner, Hugo
    Znoj, Hansjoerg
    Grolimund, Johannes
    von Kaenel, Roland
    VASCULAR MEDICINE, 2013, 18 (05) : 257 - 262
  • [43] Dual Anticoagulant and Antiplatelet Therapy for Coronary Artery Disease and Peripheral Artery Disease Patients
    Mackman, Nigel
    Spronk, Henri M. H.
    Stouffer, George A.
    ten Cate, Hugo
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2018, 38 (04) : 726 - 732
  • [44] Effects of Supervised Exercise Therapy on Muscle Function During Walking in Patients with Peripheral Artery Disease
    Anderson, Cody P.
    Pipinos, Iraklis I.
    Johanning, Jason M.
    Myers, Sara A.
    Rahman, Hafizur
    BIOENGINEERING-BASEL, 2024, 11 (11):
  • [45] CORONARY-ARTERY DISEASE IN PATIENTS WITH PERIPHERAL VASCULAR-DISEASE
    TAYLOR, PR
    HOUGHTON, AD
    TYRRELL, R
    BRITISH JOURNAL OF SURGERY, 1994, 81 (09) : 1394 - 1394
  • [46] Severity of coronary artery disease in patients with and without peripheral arterial disease
    Sukhija, R
    Yalamanchili, K
    Aronow, WS
    CHEST, 2003, 124 (04) : 147S - 148S
  • [47] CORONARY-ARTERY DISEASE IN PATIENTS WITH PERIPHERAL VASCULAR-DISEASE
    GAJRAJ, H
    JAMIESON, CW
    BRITISH JOURNAL OF SURGERY, 1994, 81 (03) : 333 - 342
  • [48] Prevalence of peripheral arterial disease in hospitalized patients with coronary artery disease
    Tomasson, J
    Dieter, RS
    Gudjonsson, T
    Tanke, T
    McBride, PE
    CIRCULATION, 2002, 106 (16) : E116 - E117
  • [49] Peripheral Artery Disease and Kidney Function in Hypertensive Patients
    Sarmento, Carolina
    Pereira, Telmo
    Maldonado, Joao
    Conde, Jorge
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2013, 100 (04) : 362 - 367
  • [50] Exercise capacity in patients with coronary heart disease and peripheral artery disease, receiving long-term mildronate therapy
    Dzerve, V. Ya
    Pozdnyakov, Yu. M.
    RUSSIAN JOURNAL OF CARDIOLOGY, 2011, (01): : 49 - 55